Skip to main navigation Skip to search Skip to main content

A phase III study of Pomalidomide and low dose Dexamethasone with or without Pembrolizumab (MK3475) in refractory or relapsed and refractory Multiple Myeloma (rrMM)

    Project: Research

    Project Details

    StatusActive
    Effective start/end date10/3/16 → …